Status:
COMPLETED
Confocal Laser Endomicroscopy for Brain Tumors
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Brain Tumor
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prognosis of glioblastoma patients highly depends on resection extent. Various strategies have been introduced to overcome the dilemma of intraoperative tumor identification. In gastroenterology,...
Detailed Description
Background: The prognosis of glioblastoma patients highly depends on resection extent. Various strategies have been introduced to overcome the dilemma of intraoperative tumor identification. In gast...
Eligibility Criteria
Inclusion
- The patient is undergoing neurosurgery for a suspected brain tumor and amenable to surgical resection by fluorescent guided technique
- The patient has an indication for tumor resection
- Macroscopic tumor visualization using sodium fluorescein is planned, concentration 5-10mg/kg
- The patient is older than 18 years
- Written consent
Exclusion
- Stereotactic biopsy procedure
- Patients with any kind of contraindication to the use of fluorescein sodium
- Vulnerable persons (pregnant women, patients with Glasgow Coma Scale below 14)
- Participation in other ongoing clinical trials with one exception: double inclusions are allowed provided that no interaction with NaF is to be expected
- People who do not want to participate in the study
- Tumors that do not exactly match the inclusion criteria
- Emergency procedures in which no consent was obtained before the operation.
- Multiple surgeries on the same patient.
Key Trial Info
Start Date :
June 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04280952
Start Date
June 5 2020
End Date
June 30 2023
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Neurosurgery, Bern University Hospital
Bern, Switzerland, 3010